title: Rapid HIV testing and counselling in labour in a northern Nigerian setting.
abstract: Between April and August 2004, all pregnant women in labour at JUTH, were offered rapid HIV testing and counselling with opportunity to decline testing. HIV positive women were offered the standard nevirapine mono-therapy prophylaxis regimen (HIVNET 012). Four hundred and thirty (99.8%) of the 431 pregnant women who were offered rapid HIV testing and counselling, agreed to test. A sero-conversion rate of 2.1% (5 of 235) was found among women who had previously tested negative for HIV during the index pregnancy. A seroprevalence rate of 9.6% (16 of 166) was found among women with unknown HIV status. One patient who had an indeterminate HIV status prior to labour tested positive in labour. Rapid HIV testing and counselling in labour is a useful practice in high prevalence settings since it detects a substantial number of HIV-infected women and HIV-exposed babies that would otherwise have missed interventions to prevent MTCT.
authors.affiliation: Department of Obstetrics and Gynaecology, APIN Project, Jos University Teaching Hospital, Nigeria. atsagay58@yahoo.com
authors.forename: A S
authors.initials: AS
authors.lastname: Sagay
authors.forename: J
authors.initials: J
authors.lastname: Musa
authors.forename: A S
authors.initials: AS
authors.lastname: Adewole
authors.forename: G E
authors.initials: GE
authors.lastname: Imade
authors.forename: C C
authors.initials: CC
authors.lastname: Ekwempu
authors.forename: S
authors.initials: S
authors.lastname: Kapiga
authors.forename: J L
authors.initials: JL
authors.lastname: Sankale
authors.forename: J
authors.initials: J
authors.lastname: Idoko
authors.forename: P
authors.initials: P
authors.lastname: Kanki
mesh_terms: D000293:Adolescent; D000328:Adult; D019380:Anti-HIV Agents / Q000627:therapeutic use; D003376:Counseling; D003430:Cross-Sectional Studies; D005260:Female; D015658:HIV Infections / Q000175:diagnosis* / Q000453:epidemiology / Q000517:prevention & control / Q000635:transmission; D006679:HIV Seropositivity / Q000453:epidemiology; D015528:HIV Seroprevalence; D006801:Humans; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control; D007743:Labor, Obstetric; D019829:Nevirapine / Q000627:therapeutic use; D009549:Nigeria / Q000453:epidemiology; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000175:diagnosis* / Q000453:epidemiology
chemical_list: D019380:Anti-HIV Agents; D019829:Nevirapine